Cannabis receptor haplotype associated with fewer cannabis dependence symptoms in adolescents.
- Authors
- Hopfer, Christian J; Young, Susan E; Purcell, Shaun; Crowley, Thomas J; Stallings, Michael C; Corley, Robin P; Rhee, Soo Hyun; Smolen, Andrew; Krauter, Ken; Hewitt, John K; Ehringer, Marissa A
- Year
- 2006
- Journal
- American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics
- PMID
- 16917946
- DOI
- 10.1002/ajmg.b.30378
- PMCID
- PMC2564870
Cannabis is a major substance of abuse, and the gene encoding for the central cannabinoid receptor (CNR1) is a logical candidate gene for vulnerability toward developing symptoms of cannabis dependence. We studied four single-nucleotide polymorphisms (SNPs) in the CNR1 gene for association with having one or more symptoms of cannabis dependence in 541 adolescent subjects who had all tried cannabis five or more times. Cases (327) were defined as those who had tried marijuana and developed one or more symptoms, and controls (214) as those who had tried marijuana but developed no dependence symptoms. Cannabis dependence symptoms were assessed in these youth when they were 17 or older with the Composite International Diagnostic Interview--Substance Abuse Module. Univariate (single-marker) association tests demonstrated that SNP rs806380, located in intron 2 of the CNR1 gene, was significantly associated with developing one or more cannabis dependence symptoms, with the G allele having a protective effect (P < 0.02). This was consistent with the results of the global haplotype test (P < 0.01). One of the common haplotypes examined (present in 21% of the subjects) was significantly associated with a lower rate of having one or more cannabis dependence symptoms. Our findings provide evidence suggesting that a common CNR1 haplotype is associated with developing fewer cannabis dependence symptoms among adolescents who have experimented with cannabis.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
No citations found.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Association of Dopamine Transporter Gene (DAT1) 40βbp 3' UTR VNTR Polymorphism (rs28363170) and Cannabis Use Disorder. | Olasore HS et al. | β | 2023 | β |
| Cannabis Pharmacogenomics: A Path to Personalized Medicine. | Babayeva M et al. | β | 2023 | β |
| Supporting Machine Learning Model in the Treatment of Chronic Pain. | Visibelli A et al. | β | 2023 | β |
| Biomarkers of the Endocannabinoid System in Substance Use Disorders. | Navarrete F et al. | β | 2022 | β |
| FOXN3 and GDNF Polymorphisms as Common Genetic Factors of Substance Use and Addictive Behaviors. | Vereczkei A et al. | β | 2022 | β |
| Molecular Alterations of the Endocannabinoid System in Psychiatric Disorders. | Navarro D et al. | β | 2022 | β |
| The cannabinoid receptor-1 gene interacts with stressful life events to increase the risk for problematic alcohol use. | Bornscheuer L et al. | β | 2022 | β |
| The genetic aetiology of cannabis use: from twin models to genome-wide association studies and beyond. | Verweij KJH et al. | β | 2022 | β |
| The systems medicine of cannabinoids in pediatrics: the case for more pediatric studies. | O'Dell CP et al. | β | 2022 | β |
| Endocannabinoid Gene Γ Gene Interaction Association to Alcohol Use Disorder in Two Adolescent Cohorts. | Elkrief L et al. | β | 2021 | β |
| <i>FAAH</i> and <i>CNR1</i> Polymorphisms in the Endocannabinoid System and Alcohol-Related Sleep Quality. | Soundararajan S et al. | β | 2021 | β |
| <i>CNR1</i> and <i>FAAH</i> variation and affective states induced by marijuana smoking. | Palmer RHC et al. | β | 2019 | β |
| Priority Considerations for Medicinal Cannabis-Related Research. | Bonn-Miller MO et al. | β | 2019 | β |
| The initiation of cannabis use in adolescence is predicted by sex-specific psychosocial and neurobiological features. | Spechler PA et al. | β | 2019 | β |
| Gene variants and educational attainment in cannabis use: mediating role of DNA methylation. | Gerra MC et al. | β | 2018 | β |
| Pharmacogenetics of Cannabinoids. | Hryhorowicz S et al. | β | 2018 | β |
| Cannabinoid Receptor Type 1 and mu-Opioid Receptor Polymorphisms Are Associated With Cyclic Vomiting Syndrome. | Wasilewski A et al. | β | 2017 | β |
| Developmentally Specific Associations Between CNR1 Genotype and Cannabis Use Across Emerging Adulthood. | Ashenhurst JR et al. | β | 2017 | β |
| Genetic and Environmental Factors Associated with Cannabis Involvement. | Bogdan R et al. | β | 2016 | β |
| Lifetime use of cannabis from longitudinal assessments, cannabinoid receptor (CNR1) variation, and reduced volume of the right anterior cingulate. | Hill SY et al. | β | 2016 | β |
| Common single nucleotide variants underlying drug addiction: more than a decade of research. | BΓΌhler KM et al. | β | 2015 | β |
| Endocannabinoid signalling in reward and addiction. | Parsons LH et al. | β | 2015 | β |
| Have the genetics of cannabis involvement gone to pot? | Agrawal A et al. | β | 2014 | β |
| Marijuana: respiratory tract effects. | Owen KP et al. | β | 2014 | β |
| Pharmacogenetics of the G protein-coupled receptors. | Thompson MD et al. | β | 2014 | β |
| Trajectory of adolescent cannabis use on addiction vulnerability. | Hurd YL et al. | β | 2014 | β |
| Colorado Twin Registry: an update. | Rhea SA et al. | β | 2013 | β |
| Considering gender in cannabinoid research: a step towards personalized treatment of marijuana addicts. | Fattore L | β | 2013 | β |
| Impulsivity, variation in the cannabinoid receptor (CNR1) and fatty acid amide hydrolase (FAAH) genes, and marijuana-related problems. | Bidwell LC et al. | β | 2013 | β |
| Associations between cannabinoid receptor-1 (CNR1) variation and hippocampus and amygdala volumes in heavy cannabis users. | Schacht JP et al. | β | 2012 | β |
| Cannabinoid receptor 1 gene is associated with alcohol dependence. | Marcos M et al. | β | 2012 | β |
| Contributions of endocannabinoid signaling to psychiatric disorders in humans: genetic and biochemical evidence. | Hillard CJ et al. | β | 2012 | β |
| The genetic basis of the endocannabinoid system and drug addiction in humans. | LΓ³pez-Moreno JA et al. | β | 2012 | β |
| The genetics of substance dependence. | Wang JC et al. | β | 2012 | β |
| Association Study of Two Cannabinoid Receptor Genes, CNR1 and CNR2, with Methamphetamine Dependence. | Okahisa Y et al. | β | 2011 | β |
| Cannabinoid receptor 1 gene polymorphisms and marijuana misuse interactions on white matter and cognitive deficits in schizophrenia. | Ho BC et al. | β | 2011 | β |
| CNR1 gene polymorphisms in addictive disorders: a systematic review and a meta-analysis. | Benyamina A et al. | β | 2011 | β |
| Endocannabinoid influence in drug reinforcement, dependence and addiction-related behaviors. | Serrano A et al. | β | 2011 | β |
| Individual and additive effects of the CNR1 and FAAH genes on brain response to marijuana cues. | Filbey FM et al. | β | 2010 | β |
| Mechanisms underlying the lifetime co-occurrence of tobacco and cannabis use in adolescent and young adult twins. | Agrawal A et al. | β | 2010 | β |
| Methamphetamine neurotoxicity increases brain expression and alters behavioral functions of CBβ cannabinoid receptors. | Bortolato M et al. | β | 2010 | β |
| Candidate genes for cannabis use disorders: findings, challenges and directions. | Agrawal A et al. | β | 2009 | β |
| Cannabinoid receptors in brain: pharmacogenetics, neuropharmacology, neurotoxicology, and potential therapeutic applications. | Onaivi ES | β | 2009 | β |
| Evidence for association between polymorphisms in the cannabinoid receptor 1 (CNR1) gene and cannabis dependence. | Agrawal A et al. | β | 2009 | β |
| Interaction between two independent CNR1 variants increases risk for cocaine dependence in European Americans: a replication study in family-based sample and population-based sample. | Zuo L et al. | β | 2009 | β |
| Sex differences in the self-administration of cannabinoids and other drugs of abuse. | Fattore L et al. | β | 2009 | β |
| The association between cannabinoid receptor 1 gene (CNR1) and cannabis dependence symptoms in adolescents and young adults. | Hartman CA et al. | β | 2009 | β |
| Association of the cannabinoid receptor gene (CNR1) with ADHD and post-traumatic stress disorder. | Lu AT et al. | β | 2008 | β |
| Blunted psychotomimetic and amnestic effects of delta-9-tetrahydrocannabinol in frequent users of cannabis. | D'Souza DC et al. | β | 2008 | β |
| Cannabinoid receptor 1 gene association with nicotine dependence. | Chen X et al. | β | 2008 | β |
| Early cannabis use and DSM-IV nicotine dependence: a twin study. | Agrawal A et al. | β | 2008 | β |
| Gene expression of opioid and dopamine systems in mouse striatum: effects of CB1 receptors, age and sex. | Gerald TM et al. | β | 2008 | β |
| The CNR1 gene as a pharmacogenetic factor for antipsychotics rather than a susceptibility gene for schizophrenia. | Hamdani N et al. | β | 2008 | β |
| The genetics of alcohol and other drug dependence. | Dick DM et al. | β | 2008 | β |
| A genome-wide scan for loci influencing adolescent cannabis dependence symptoms: evidence for linkage on chromosomes 3 and 9. | Hopfer CJ et al. | β | 2007 | β |
| Association between single nucleotide polymorphisms in the cannabinoid receptor gene (CNR1) and impulsivity in southwest California Indians. | Ehlers CL et al. | β | 2007 | β |
| Cannabis reward: biased towards the fairer sex? | McGregor IS et al. | β | 2007 | β |
| Genotype effects of CHRNA7, CNR1 and COMT in schizophrenia: interactions with tobacco and cannabis use. | Zammit S et al. | β | 2007 | β |